The MCDH Blog

MCDH Patients Avoid Contaminated Steroid Noted in National FDA Investigation
—Posted Friday, October 5th, 2012 at 5:24 pm—
« »

I pleased to say that our patients were not injected with contaminated steroid because of our “best practices” approach of buying our drugs only from reliable sources.

Lois Leister, the pharmacy Director at MCDH, has confirmed that Mendocino Coast District Hospital has at no time purchased any methylprednisolone acetatate injection which has been  produced and distributed by New England Compounding Center (NECC) in Framingham, Massachusetts.

The FDA investigation into the exact source of the outbreak is still ongoing, but the outbreak that has been associated with this product is preservative-free methylprednisolone acetate (80mg/ml),  an injectable steroid , produced and distributed by New England Compounding Center (NECC) in Framingham, Massachusetts.  CDC’s interim data show that all infected patients received injection with this product.

To read the MedWatch safety alert, incliding links to the FDA statement, Q&As, and list of recalled products, click here. The Dept. of Anesthesia would like to alleviate any concerns by patients or their families, by stating that only methylprednisolone, manufactured by Pfizer Pharmaceuticals, has been used in epidural steroid injections performed at the Mendocino Coast District Hospital.

 

 

Comments are closed.

 

Services

Services